Sympathomimetic medications: Nursing pharmacology

1,221views

Sympathomimetic medications: Nursing pharmacology

MidTerm

MidTerm

Renal system anatomy and physiology
Regulation of renal blood flow
The role of the kidney in acid-base balance
Physiologic pH and buffers
Antidiuretic hormone
Renin-angiotensin-aldosterone system
Osmoregulation
Glomerular filtration
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Distal convoluted tubule
Loop of Henle
Proximal convoluted tubule
Renal clearance
Hydration
Phosphate, calcium and magnesium homeostasis
Sodium homeostasis
Potassium homeostasis
Plasma anion gap
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Chronic kidney disease (CKD): Nursing
Renal failure: Pathology review
Amyloidosis
Urinary system: Renal failure
Erythropoietin
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Hyperkalemia
Hypokalemia
Hypercalcemia
Hypocalcemia
Hypermagnesemia
Hypomagnesemia
Loop diuretics
Thiazide and thiazide-like diuretics
Osmotic diuretics
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
ACE inhibitors, ARBs and direct renin inhibitors
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Calcium channel blockers
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Adrenergic antagonists: Beta blockers
Sympatholytics: Alpha-2 agonists
Sympathomimetics: Direct agonists
Dialysis care: Nursing
Dialysis
Urea recycling
Nitrogen and urea cycle
Chronic kidney disease
Acute kidney injury (AKI): Nursing process (ADPIE)
Acute kidney injury: Clinical
Urinary tract infections (UTIs): Nursing process (ADPIE)
Urinary tract infections: Pathology review
Renal and urinary calculi: Nursing
Polycystic kidney disease (PKD): Nursing
Polycystic kidney disease
Renal cancer: Nursing
Bladder tumors: Nursing
Hygiene - Ostomy care: Nursing skills
Prostate cancer: Nursing
Prostate cancer
Testicular cancer: Nursing
Cryptorchidism: Nursing
Hyponatremia: Clinical
Hyperphosphatemia
Hyperparathyroidism
Hypophosphatemia
Hypernatremia
Complete metabolic panel (CMP) - Chloride: Nursing
Anemia - Iron-deficiency: Nursing

Notes





SYMPATHOMIMETIC MEDICATIONS, PART 1/2
DRUG NAME
dobutamine
dopamine
CLASS
Sympathomimetics
β1-agonist
β1- and α-agonist
MECHANISM of ACTION
Stimulates β1-adrenergic receptors → increases contractility and cardiac output
Stimulates β1-adrenergic receptors → increases contractility and cardiac output

Stimulates β1- and α-receptors → vasoconstriction → increases blood pressure
INDICATIONS
  • Cardiac decompensation
  • Unlabeled: cardiogenic shock in children
  • Shock
  • Hypotension
  • Unlabeled: bradycardia
  • Cardiac arrest
ROUTE(S) of ADMINISTRATION
  • IV
  • IV
SIDE EFFECTS
  • CV: palpitations, tachycardia, hypertension, angina, arrhythmias
  • GI: nausea, vomiting
  • CNS: cerebral hemorrhage
  • Dopamine, epinephrine, norepinephrine: extravasation (boxed warning), tissue necrosis, sloughing, gangrene
  • Epinephrine: hyperglycemia (clients with diabetes)
CONTRAINDICATIONS & CAUTIONS
  • Pregnancy and breastfeeding
  • Elderly clients
  • Hypertension or coronary artery disease
  • Dobutamine
    • hypertrophic cardiomyopathy with outflow tract obstruction
  • Norepinephrine:
    • hypovolemia, mesenteric or peripheral thrombosis
  • Dopamine: 
    • tachyarrhythmias, ventricular fibrillation, pheochromocytoma, hypovolemia
  • Isoproterenol: 
    • tachyarrhythmias, angina pectoris, cardiac glycoside toxicity
  • Epinephrine:
    • closed-angle glaucoma, non-anaphylactic shock

Drug interactions:
  • Dobutamine: COMT inhibitors
  • Dopamine, epinephrine, norepinephrine: MAO inhibitors, TCAs
  • Combining sympathomimetic medications


SYMPATHOMIMETIC MEDICATIONS, PART 2/2
DRUG NAME
epinephrine (Adrenalin,
Adrenaclick, Epipen)

norepinephrine (Levophed)
isoproterenol (Isuprel)
CLASS
Sympathomimetics
Bronchodilator Nonselective adrenergic agonist
Nonselective
adrenergic agonist
Nonselective beta-adrenergic agonist
MECHANISM of ACTION
Stimulates β1- and β2-agonist →
bronchodilation, cardiac and CNS stimulation
Stimulates β-receptors in heart → increases contractility, heart rate, and cardiac output

Stimulates β1- and α-receptors → vasoconstriction → increases blood pressure

Stimulates β1- and β2-agonist →
bronchodilation, cardiac and CNS stimulation
INDICATIONS
  • Acute asthmatic attacks
  • Bronchospasm
  • Anaphylaxis, allergic reactions
  • Cardiac arrest
  • Shock
  • Acute hypotension
  • Shock
  • Episodes of heart block
  • Cardiac arrest, CPR
  • Bronchospasm occurring during anesthesia
  • Shock, congestive heart failure
ROUTE(S) of ADMINISTRATION
  • IV
  • IM
  • INH
  • ET tube
  • IV
  • IV
  • IM
SIDE EFFECTS
  • CV: palpitations, tachycardia, hypertension, angina, arrhythmias
  • GI: nausea, vomiting
  • CNS: cerebral hemorrhage
  • Dopamine, epinephrine, norepinephrine: extravasation (boxed warning), tissue necrosis, sloughing, gangrene
  • Epinephrine: hyperglycemia (clients with diabetes)
CONTRA-INDICATIONS & CAUTIONS
  • Pregnancy and breastfeeding
  • Elderly clients
  • Hypertension or coronary artery disease
  • Dobutamine
    • hypertrophic cardiomyopathy with outflow tract obstruction
  • Norepinephrine:
    • hypovolemia, mesenteric or peripheral thrombosis
  • Dopamine: 
    • tachyarrhythmias, ventricular fibrillation, pheochromocytoma, hypovolemia
  • Isoproterenol: 
    • tachyarrhythmias, angina pectoris, cardiac glycoside toxicity
  • Epinephrine:
    • closed-angle glaucoma, non-anaphylactic shock

Drug interactions:
  • Dobutamine: COMT inhibitors
  • Dopamine, epinephrine, norepinephrine: MAO inhibitors, TCAs
  • Combining sympathomimetic medications
NURSING CONSIDERATIONS for
SYMPATHOMIMETIC MEDICATIONS
ASSESSMENT & MONITORING

Assessment and monitoring - norepinephrine

Assessment
  • Weight
  • Orientation, LOC
  • Hemodynamic status
  • Respiratory status 

Intervention and monitoring
  • Administer via central line
  • Low dose titrated based on client’s response

Monitoring
  • Hemodynamic status
  • Intake and output
  • LOC
  • Side effects
    • Paresthesias, cool extremities
    • Extravasation
      • Stop infusion
      • Notify health care provider
      • Administer phentolamine mesylate subcutaneously
  • Evaluate for the therapeutic response of blood pressure stabilization.
CLIENT EDUCATION
  • Purpose of medication: increase their blood pressure
  • Administered as a continuous infusion, adjusted as needed
Author: Victoria S. Recalde, MD
Author: Kelsey LaFayette, BAN, RN
Illustrator: Elijah Lee, MScBMC

Transcript

Watch video only

Sympathomimetics are medications that mimic the effect of endogenous catecholamines, like norepinephrine and epinephrine. As a result, these medications activate the sympathetic nervous system, which in turn triggers the fight or flight response, ultimately increasing the heart rate and blood pressure, as well as slowing down digestion. This response maximizes blood flow to the muscles and brain.

Now, sympathomimetic medications include dobutamine, dopamine, norepinephrine, epinephrine, and isoproterenol. All of them are administered intravenously, while isoproterenol can also be given intramuscularly, and epinephrine can also be administered intramuscularly, as well as through endotracheal tube or inhalation.

Once administered, sympathomimetic medications act by stimulating adrenergic receptors. Now, there are two main groups of adrenergic receptors: the alpha receptors, and beta receptors. Alpha adrenergic receptors are mainly located on the walls of blood vessels of the skin, as well as the gastrointestinal and genitourinary systems, and when stimulated, they cause vasoconstriction and decreased blood flow to these tissues.

On the other hand, beta receptors have two main subtypes: beta-1 and beta-2. Beta-1 adrenergic receptors are mainly located in the heart, and when activated, they increase the heart rate and contractility, which helps pump out more blood. On the other hand, beta-2 adrenergic receptors are found on smooth muscle cells in the walls of blood vessels supplying skeletal muscles and the brain, so their activation leads to vasodilation and increased blood flow to these tissues; and in the lungs, they cause bronchodilation.

Each type of adrenergic agonists stimulate these receptors to a different degree, which makes them useful to treat different conditions. But in general, all of them activate beta-1 receptors, so they all increase heart contractility, helping in the treatment of conditions where the cardiac output is decreased.

Now, all of these medications can be used to treat cardiac decompensation and shock. In addition, dopamine can also be used to treat bradycardia and post-cardiac arrest after shock. Norepinephrine is mainly used to treat acute hypotension and shock. Epinephrine is used to treat cardiac arrest, shock, and anaphylactic reactions; and because of its action on beta-2 adrenergic receptors, it’s also useful to treat acute asthmatic attacks and bronchospasm. Finally, isoproterenol is used in the treatment of cardiac arrest, episodes of heart block, congestive heart failure, shock, and bronchospasm that may occur during anesthesia.

Now, most side effects of these medications are the result of their action on adrenergic receptors. Clients on sympathomimetics may also experience gastrointestinal side effects, such as nausea and vomiting. Sympathomimetics can also be associated with cardiovascular side effects, including hypertension, and tachycardia, while more serious side effects of adrenergic agonists include angina and arrhythmias, while excessive hypertension can even result in cerebral hemorrhage.

Dopamine, epinephrine, and norepinephrine have a boxed warning for extravasation, which can lead to tissue necrosis, sloughing, and gangrene. Finally, epinephrine can cause hyperglycemia in clients with diabetes.

As far as contraindications go, all sympathomimetic medications should be used with caution during pregnancy and breastfeeding, as well as in elderly clients and those with hypertension or coronary artery disease. In addition, dobutamine is contraindicated in clients with hypertrophic cardiomyopathy with outflow tract obstruction.

On the other hand, norepinephrine should be used with caution when there’s hypovolemia or mesenteric or peripheral thrombosis, and clients on this medication should have adequate blood volume to avoid reduced blood flow, ischemia, and tissue hypoxia from the vasoconstriction.

Dopamine is also contraindicated in clients with tachyarrhythmias, ventricular fibrillation, pheochromocytoma, and hypovolemia. Next, isoproterenol is contraindicated in clients with tachyarrhythmias or angina pectoris, as well as in those experiencing cardiac glycoside toxicity. Finally, epinephrine shouldn’t be given to clients with closed-angle glaucoma and those having a non-anaphylactic shock.

Key Takeaways

Sympathomimetic medications are drugs that mimic the effects of the sympathetic nervous system. They work by mimicking the effect of endogenous catecholamines, like norepinephrine and epinephrine, and can be used to treat conditions such as cardiac decompensation, shock, anaphylaxis, bronchospasm, and bradycardia post-cardiac arrest. Some common examples of sympathomimetic medications include dobutamine, dopamine, norepinephrine, epinephrine, and isoproterenol.

Once administered, these medications stimulate two types of adrenergic receptors, alpha, and beta. With alpha-adrenergic receptor stimulation, vasoconstriction occurs, whereas stimulation of beta-1 adrenergic receptors causes increased heart rate and contractility, and stimulation of beta-2 adrenergic receptors causes vasodilation and bronchodilation.

Common side effects of sympathomimetics include gastrointestinal disturbances, hypertension, and arrhythmias. Nursing considerations for clients receiving sympathomimetics include monitoring their hemodynamic status; titrating doses as needed; monitoring for side effects; and assessing for the desired therapeutic response. Client education is focused on what to expect during treatment.

Sources

  1. "Karch’s Focus on Nursing Pharmacology. 9th edition. ISBN: 978-1-975180-40-9 " LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach. 9th edition. ISBN: 978-0-323-39916-6 " Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference. 36th edition. ISBN: 978-0-323-93072-7" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN. 9th Edition. ISBN: 978-0-323-79530-2" Saunders (2022)
  5. "Shock - Classification and Pathophysiological Principles of Therapeutics. 15(2):102-113" Curr Cardiol Rev (2019)
  6. "Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis. 22(2):196-203" West J Emerg Med (2021 Feb 16)
  7. "Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis. 148(5):1307-1315" J Allergy Clin Immunol (2021 )